Actively Recruiting
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Led by Navy General Hospital, Beijing · Updated on 2024-10-01
54
Participants Needed
1
Research Sites
308 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this phase 1/2 trial is to test the safety and efficacy of Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT in treating patients with higher-risk MDS.
CONDITIONS
Official Title
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is able to meet all clinical trial requirements according to the investigator's opinion
- Patient is willing and able to follow the study visit schedule and protocol requirements
- Diagnosed with higher-risk Myelodysplastic Syndromes according to WHO standard criteria
You will not qualify if you...
- Active or uncontrolled infections requiring systemic treatment within 14 days before enrollment
- Unstable systemic disease, including severe cardiac, liver, kidney, or metabolic disease requiring therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Navy General Hospital
Beijing, Beijing Municipality, China, 100048
Actively Recruiting
Research Team
L
Liren Qian, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here